ASML's warning of a substantial decline in its sales to China, despite strong overall earnings, signals a shift in the global semiconductor landscape. This development could create opportunities for other equipment manufacturers poised to gain market share amid evolving trade dynamics.
Published on October 15
Trade restrictions are reshaping the entire semiconductor industry, creating new winners and losers. Companies positioned outside these constraints could see significant market share gains.
The chip war represents one of the most important geopolitical and economic battlegrounds of our time. These companies sit at the heart of this transformation.
As ASML faces China restrictions, competitors and alternative suppliers may capture new opportunities. This group includes the key players positioned to benefit from this shift.
The global semiconductor landscape is experiencing a major shift as trade restrictions reshape supply chains. When a dominant player like ASML faces export controls to China, it creates potential opportunities for competitors to gain market share and fill supply gaps in this critical technology sector.
This group includes companies across the semiconductor ecosystem - from advanced equipment manufacturers to chip foundries. These firms could benefit from the realignment of global chip production as geopolitical tensions continue to influence trade patterns and market dynamics.
These companies were handpicked by professional analysts as key players positioned to navigate the evolving chip war. The selection includes both established leaders and potential beneficiaries of supply chain shifts, offering tactical exposure to this critical inflection point in technology.
Interpretation of the basket's total market capitalisation and weight concentration among constituents.
ASML: $380.13B
TSM: $1.20T
LRCX: $174.41B
Get the full story on this Basket. Read our detailed article on its risks and potential.
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Part of Exinity Group 2015, serving over a million customers globally.
Gilead Sciences has secured FDA approval for a new once-daily HIV combination pill, streamlining therapy for millions of suppressed patients. This regulatory milestone spotlights investment opportunities in pioneering biopharmaceutical companies and drug delivery developers focused on advanced antiviral treatments.
Disney is suing the FCC to block an early license review of its ABC stations, arguing the move is politically motivated retaliation against its news coverage. This unprecedented legal battle highlights the growing regulatory risks for traditional broadcasters and underscores the structural advantages of unregulated digital streaming platforms.
SK Hynix has unveiled a record-breaking 40 trillion won share buyback fueled by soaring demand for its AI memory chips. This historic capital return creates a compelling investment theme centered on high-bandwidth memory producers and the specialized equipment manufacturers that enable their advanced production.
Earn 6% AER on uninvested cash with daily interest payments.
+5
Here are a few of the assets in this group. Create an account to unlock the full list.
13 of 15 assets in this group are rated Buy by professional analysts.
